Djordjevic Katarina, Milojevic Samanovic Andjela, Veselinovic Mirjana, Zivkovic Vladimir, Mikhaylovsky Victor, Mikerova Maria, Reshetnikov Vladimir, Jakovljevic Vladimir, Nikolic Turnic Tamara
Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića 69, 34000 Kragujevac, Serbia.
Department of Dentistry, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića 69, 34000 Kragujevac, Serbia.
Antioxidants (Basel). 2023 Oct 31;12(11):1938. doi: 10.3390/antiox12111938.
The aim of this meta-analysis is to explore all the available literature to obtain updated data about the potential use of antioxidants in the treatment of rheumatoid arthritis (RA) and its ability to reduce disease progression and cardiovascular risk.
This systematic review and meta-analysis was performed strictly in accordance with the PRISMA guidelines. English and Chinese databases were searched with a retrieval time up to March 2023. These databases included the PubMed, Embase, Medline Complete, Web of Sciences and Cochrane Collaboration, Wanfang, China National Knowledge Infrastructure, and VIP databases. This literature search was formulated by the two researchers independently. The search strategy consists of reading, collecting the literature, and conducting the preliminary screening. After that, they provide the final selection of the literature according to the inclusion criteria and data extraction. Also, for all studies, the risk bias was assessed to evaluate the quality of the included references. The content of the risk assessment of bias included the following criteria: random allocation method, allocation plan hiding, blind method, completeness of result data, and selectivity of reporting of results, as well as other biases. The main outcomes were clinical efficiency of antioxidant therapy (C-reactive protein, DAS28 score, HAQ, Number of tender joints, etc.) and oxidative stress indicators (catalase, superoxide dismutase, or total antioxidant capacity).
We observed, in most of the studies, the small or moderate effects of antioxidant treatment. The mean effect size is 0.525, and that means that moderate effects were observed in 30 selected RCTs. Also, this effect is confirmed in the 1652 patients with RA with the mean confidence interval of 0.276 (lower limit) and 0.983 (upper limit). Cohen coefficient was calculated at 0.05.
The existing evidence is that antioxidants can reduce systemic and local oxidative stress and can reduce damage as the main agent involved in autoimmune diseases such as rheumatoid arthritis.
本荟萃分析旨在探究所有可得文献,以获取有关抗氧化剂在类风湿关节炎(RA)治疗中的潜在用途及其降低疾病进展和心血管风险能力的最新数据。
本系统评价和荟萃分析严格按照PRISMA指南进行。检索了英文和中文数据库,检索时间截至2023年3月。这些数据库包括PubMed、Embase、Medline Complete、Web of Sciences和Cochrane协作网、万方、中国知网和维普数据库。文献检索由两名研究人员独立完成。检索策略包括阅读、收集文献并进行初步筛选。之后,他们根据纳入标准和数据提取提供最终的文献选择。此外,对所有研究进行风险偏倚评估,以评估纳入参考文献的质量。偏倚风险评估的内容包括以下标准:随机分配方法、分配方案隐藏、盲法、结果数据的完整性、结果报告的选择性以及其他偏倚。主要结局为抗氧化剂治疗的临床疗效(C反应蛋白、DAS28评分、健康评估问卷、压痛关节数等)和氧化应激指标(过氧化氢酶、超氧化物歧化酶或总抗氧化能力)。
在大多数研究中,我们观察到抗氧化剂治疗有小或中等程度的效果。平均效应大小为0.525,这意味着在30项入选的随机对照试验中观察到了中等程度的效果。此外,在1652例类风湿关节炎患者中也证实了这一效果,平均置信区间为0.276(下限)和0.983(上限)。计算得到的科恩系数为0.05。
现有证据表明,抗氧化剂可降低全身和局部氧化应激,并可作为类风湿关节炎等自身免疫性疾病的主要参与因素减少损伤。